# Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer

> **NCT01558947** · PHASE2 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 2 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Peri-operative chemotherapy of ECX
- **DRUG:** Peri-operative chemotherapy of XP

## Key facts

- **NCT ID:** NCT01558947
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-06
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2012-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01558947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01558947, "Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01558947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
